Search Results
Monocrotaline 100mg | ≥99%
CSNpharm
Monocrotaline is a naturally occuring pyrrolizidine alkaloid which can cause pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature.
More Information Supplier PageMonocrotaline 250mg | ≥99%
CSNpharm
Monocrotaline is a naturally occuring pyrrolizidine alkaloid which can cause pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature.
More Information Supplier Pagealpha-Asarone 1g | ≥99%
CSNpharm
alpha-Asarone is a naturally occuring inhibitor of both HMG-CoA reductase (IC50 = 3 mM) and certain isoforms of the cytochrome P450 superfamily of enzymes (IC50 = 55.2 and 65.2 μg/ml for CYP2D6 and CYP3A4, respectively), with neuroprotective, anti-oxidative, anticonvulsive and cognitive enhancing action.
More Information Supplier PageNefiracetam 100mg | ≥99%
CSNpharm
Nefiracetam is a neuronal systems enhancer for Ro 5-4864-induced convulsions. Nefiracetam has GABAergic, cholinergic, and monoaminergic properties.
More Information Supplier PageNefiracetam 50mg | ≥99%
CSNpharm
Nefiracetam is a neuronal systems enhancer for Ro 5-4864-induced convulsions. Nefiracetam has GABAergic, cholinergic, and monoaminergic properties.
More Information Supplier PageAlbendazole Oxide 50mg | ≥99%
CSNpharm
Albendazole Oxide can selectively inhibit beta-tubulin polymerization, used as an anthelmintic medicine.
More Information Supplier PageAlbendazole Oxide 25mg | ≥99%
CSNpharm
Albendazole Oxide can selectively inhibit beta-tubulin polymerization, used as an anthelmintic medicine.
More Information Supplier PageMonocrotaline 10mg | ≥99%
CSNpharm
Monocrotaline is a naturally occuring pyrrolizidine alkaloid which can cause pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature.
More Information Supplier PageMonocrotaline 50mg | ≥99%
CSNpharm
Monocrotaline is a naturally occuring pyrrolizidine alkaloid which can cause pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature.
More Information Supplier Page
